Show simple item record

dc.contributor.authorBoltze, J.
dc.contributor.authorAbe, K.
dc.contributor.authorJanowski, M.
dc.date.accessioned2020-04-28T20:12:23Z
dc.date.available2020-04-28T20:12:23Z
dc.date.issued2020
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85083499635&doi=10.3389%2ffneur.2020.00171&partnerID=40&md5=91ef443aacdddcd768f5ba0521084220
dc.identifier.urihttp://hdl.handle.net/10713/12671
dc.description.abstracten_US
dc.description.urihttps://doi.org/10.3389/fneur.2020.00171en_US
dc.language.isoen_USen_US
dc.publisherFrontiers Media S.A.en_US
dc.relation.ispartofFrontiers in Neurology
dc.subjectbrainen_US
dc.subjectclinical trialsen_US
dc.subjectischemiaen_US
dc.subjectmesenchymal stem cells (MSC)en_US
dc.subjectstem cellsen_US
dc.subjectstrokeen_US
dc.subjecttranslational medicineen_US
dc.subjecttreatmenten_US
dc.titleEditorial: Cell-based Therapies for Stroke: Promising Solution or Dead End?en_US
dc.typeArticleen_US
dc.identifier.doi10.3389/fneur.2020.00171


This item appears in the following Collection(s)

Show simple item record